MaxCyte, Inc. (MXCT)
1.09
+0.01
(+0.93%)
USD |
NASDAQ |
Oct 06, 16:00
1.09
0.00 (0.00%)
After-Hours: 19:41
MaxCyte Free Cash Flow : -23.79M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.79M |
| March 31, 2026 | -29.50M |
| December 31, 2025 | -36.18M |
| September 30, 2025 | -41.23M |
| June 30, 2025 | -38.26M |
| March 31, 2025 | -32.96M |
| December 31, 2024 | -29.26M |
| September 30, 2024 | -21.23M |
| June 30, 2024 | -25.39M |
| March 31, 2024 | -30.87M |
| Date | Value |
|---|---|
| December 31, 2023 | -25.39M |
| September 30, 2023 | -33.73M |
| June 30, 2023 | -34.17M |
| March 31, 2023 | -29.45M |
| December 31, 2022 | -33.26M |
| September 30, 2022 | -27.06M |
| June 30, 2022 | -19.79M |
| March 31, 2022 | -19.26M |
| December 31, 2021 | -14.51M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Repligen Corp. | 110.15M |
| Bio-Techne Corp. | 263.22M |
| BioLife Solutions, Inc. | 7.987M |
| MindWalk Holdings Corp. | -9.062M |
| Maravai Lifesciences Holdings, Inc. | -35.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.661M |
| Cash from Investing (Quarterly) | 6.566M |
| Cash from Financing (Quarterly) | -1.42M |
| Free Cash Flow Per Share (Quarterly) | -0.0442 |
| Free Cash Flow to Equity (Quarterly) | -4.487M |
| Free Cash Flow to Firm (Quarterly) | -4.723M |
| Free Cash Flow Yield | -20.45% |